2024 asa guidance glp-1 receptor agonists perioperative Glucagon-Like Peptide-1 in Care 🔸 Should GLP-1 RAs be

But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.

Medical-grade dual receptor agonist with expert physician monitoring and personalized weight loss protocols.

Discover GLP-1 weight loss drugs in India (2026)

However, individuals with obesity or insulin resistance may experience enhanced clinical and cognitive outcomes

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Glucagon-like peptide 1 or GLP-1 is a hormone produced in the gut and released in response to food